Laura Sepp‐Lorenzino

8.3k total citations
78 papers, 4.9k citations indexed

About

Laura Sepp‐Lorenzino is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Laura Sepp‐Lorenzino has authored 78 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 19 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Laura Sepp‐Lorenzino's work include RNA Interference and Gene Delivery (25 papers), Advanced biosensing and bioanalysis techniques (15 papers) and MicroRNA in disease regulation (11 papers). Laura Sepp‐Lorenzino is often cited by papers focused on RNA Interference and Gene Delivery (25 papers), Advanced biosensing and bioanalysis techniques (15 papers) and MicroRNA in disease regulation (11 papers). Laura Sepp‐Lorenzino collaborates with scholars based in United States, Russia and Netherlands. Laura Sepp‐Lorenzino's co-authors include Neal Rosen, Samuel J. Danishefsky, Scott D. Edmondson, Bin Shi, Allen Oliff, Fuzhong F. Zheng, Ouathek Ouerfelli, Joseph P. Davide, Nancy E. Kohl and Renato Baserga and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Laura Sepp‐Lorenzino

77 papers receiving 4.8k citations

Peers

Countries citing papers authored by Laura Sepp‐Lorenzino

Since Specialization

Citations

This map shows the geographic impact of Laura Sepp‐Lorenzino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Sepp‐Lorenzino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Sepp‐Lorenzino more than expected).

Fields of papers citing papers by Laura Sepp‐Lorenzino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Sepp‐Lorenzino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Sepp‐Lorenzino. The network helps show where Laura Sepp‐Lorenzino may publish in the future.

Co-authorship network of co-authors of Laura Sepp‐Lorenzino

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Sepp‐Lorenzino. A scholar is included among the top collaborators of Laura Sepp‐Lorenzino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Sepp‐Lorenzino. Laura Sepp‐Lorenzino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advancements in Nonviral Gene Editing Strategies for Rare Diseases 2025 ·Human Gene Therapy ·(unknown), Laura Sepp‐Lorenzino, (unknown), Daniela Palacios, Begoña Sot	1
2	Efficient Downregulation of Alk4 in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy 2022 ·Nucleic Acid Therapeutics ·(unknown), (unknown), (unknown), Rubina Parmar, Klaus Charissé, Laura Sepp‐Lorenzino, Muthiah Manoharan, Annemieke Aartsma‐Rus, Maaike van Putten	11
3	Centyrin ligands for extrahepatic delivery of siRNA 2021 ·Molecular Therapy ·(unknown), Shalom D. Goldberg, Christopher S. Theile, (unknown), Kathleen Haskell, (unknown), (unknown), Rubina Parmar, Muthiah Manoharan, Mark C. Richter, Mei‐Zhen Wu, (unknown), Vasant Jadhav, Martin A. Maier, Laura Sepp‐Lorenzino, Karyn T. O’Neil, Vadim Dudkin	33
4	Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers 2019 ·Cell Metabolism ·Liliana Mâncio-Silva, Heather E. Fleming, A. B. Miller, Stuart Milstein, Abigail Liebow, Patrick Haslett, Laura Sepp‐Lorenzino, (unknown)	10
5	Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle Growth 2016 ·Molecular Therapy — Nucleic Acids ·Tayeba Khan, Hans Weber, Jillian DiMuzio, Andrea Matter, Belma Dogdas, (unknown), Anil Thankappan, Jyoti Disa, Vasant Jadhav, Laura S. Lubbers, Laura Sepp‐Lorenzino, Walter Strapps, Marija Tadin‐Strapps	71
6	An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agents 2014 ·International Journal of Pharmaceutics ·Stephanie E. Barrett, Marc Abrams, Rob S. Burke, Brian Carr, Louis S. Crocker, R. M. Garbaccio, Bonnie J. Howell, (unknown), (unknown), Andrew H. Latham, Karen Leander, Anthony Leone, Mihir Patel, Sergei Pechenov, Nicole T. Pudvah, (unknown), Laura Sepp‐Lorenzino, Eileen S. Walsh, Jonathan Williams, Steven L. Colletti	13
7	Pyridyl aminothiazoles as potent Chk1 inhibitors: Optimization of cellular activity 2012 ·Bioorganic & Medicinal Chemistry Letters ·Vadim Dudkin, Cheng Wang, Kenneth L. Arrington, Mark E. Fraley, George D. Hartman, Steven M. Stirdivant, Robert Drakas, Keith Rickert, Eileen S. Walsh, Kelly Hamilton, Carolyn A. Buser, James C.H. Hardwick, Weikang Tao, Stephen C. Beck, Xianzhi Mao, Robert B. Lobell, Laura Sepp‐Lorenzino	6
8	Quantification of Cy-5 siRNA signal in the intra-vital multi-photon microscopy images 2012 ·PubMed ·(unknown), Belma Dogdas, Sameep Mehta, Kathleen Haskell, (unknown), Ellen M. Keough, Bonnie J. Howell, (unknown), Amy G. Aslamkhan, (unknown), (unknown), Amitabha Bagchi, Laura Sepp‐Lorenzino, Weikang Tao	4
9	Regulation of microRNA-145 by growth arrest and differentiation 2010 ·Experimental Cell Research ·Gaspare La Rocca, Bin Shi, Alessandra Audia, Giovanna Ferrari‐Amorotti, Hestia Mellert, Bruno Calabretta, Steven B. McMahon, Laura Sepp‐Lorenzino, Renato Baserga	17
10	Expression of Micro‐RNA‐145 is regulated by a highly conserved genomic sequence 3′ to the pre‐miR 2010 ·Journal of Cellular Physiology ·Gaspare La Rocca, Bin Shi, Laura Sepp‐Lorenzino, Renato Baserga	10
11	An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo 2010 ·Cancer Biology & Therapy ·(unknown), Kathleen Haskell, Bonnie J. Howell, Raymond C. F. Jones, Karen Leander, R. Robinson, (unknown), Mark T. Bilodeau, J. M. HOFFMAN, Philip E.J. Sanderson, George D. Hartman, (unknown), Thomayant Prueksaritanont, Guoqiang Jiang, Qing‐Bai She, Neal Rosen, Laura Sepp‐Lorenzino, Deborah Defeo-Jones, Hans E. Huber	53
12	Mechanistically Probing Lipid-siRNA Nanoparticle-associated Toxicities Identifies Jak Inhibitors Effective in Mitigating Multifaceted Toxic Responses 2010 ·Molecular Therapy ·Weikang Tao, Xianzhi Mao, Joseph P. Davide, Bruce Ng, Mingmei Cai, Paul A. Burke, Alan B. Sachs, Laura Sepp‐Lorenzino	57
13	Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment 2009 ·Molecular Therapy ·Marc Abrams, Martin L. Koser, Jessica Seitzer, (unknown), (unknown), Weimin Wang, (unknown), Xianzhi Mao, Vasant Jadhav, Joseph P. Davide, Paul A. Burke, Alan B. Sachs, Steven M. Stirdivant, Laura Sepp‐Lorenzino	165
14	Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells 2007 ·Journal of Biological Chemistry ·Bin Shi, Laura Sepp‐Lorenzino, Marco di Prisco, Peter S. Linsley, Tiziana DeAngelis, Renato Baserga	294
15	Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling 2005 ·Molecular Cancer Therapeutics ·James S. Hardwick, Yi Yang, Chunsheng Zhang, Bin Shi, Rosemary C. McFall, Elizabeth J. Koury, Susan L. Hill, Hongyue Dai, Robert Wasserman, Robert L. Phillips, Edward J. Weinstein, Nancy E. Kohl, Michael E. Severino, John Lamb, Laura Sepp‐Lorenzino	24
16	Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases. 2000 ·PubMed ·Fuzhong F. Zheng, Scott D. Kuduk, Gabriela Chiosis, Pamela N. Münster, Laura Sepp‐Lorenzino, Samuel J. Danishefsky, Neal Rosen	73
17	A peptidomimetic inhibitor of ras functionality markedly suppresses growth of human prostate tumor xenografts in mice. Prospects for long-term clinical utility 2000 ·Cancer Chemotherapy and Pharmacology ·F. M. Sirotnak, Laura Sepp‐Lorenzino, Nancy E. Kohl, Neal Rosen, Howard I. Scher	13
18	Synthesis and evaluation of geldanamycin–testosterone hybrids 2000 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk, Christina R. Harris, Fuzhong F. Zheng, Laura Sepp‐Lorenzino, Ouathek Ouerfelli, Neal Rosen, Samuel J. Danishefsky	71
19	Cholesterol Metabolism and Tumor Cell Proliferation 1997 ·Sub-cellular biochemistry ·Peter S. Coleman, Lichuan Chen, Laura Sepp‐Lorenzino	19
20	ras Mutation: does it have clinical import? 1997 ·PubMed ·Neal Rosen, Laura Sepp‐Lorenzino	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact